Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
471. |
ECCT/15/12/02 | The Evidence for Contraceptive options and HIV Outcomes (ECHO) Trial A Multi Centre, Open label, Randomized Clinical Trial, Comparing HIV incidence and Contraceptive Benefits in Women using Depot Medroxyprogesterone Acetate, Levernogestrel (LNG) implant and Copper Intrauterine Devices (IUD). Short Title : The Evidence for Contraceptive options and HIV Outcomes (ECHO) Trial |
Principal Investigator(s) 1. Prof Elizabeth Anne Bukusi Site(s) in Kenya KEMRI-RCTP Study center , Lumumba |
11-04-2016 |
View |
472. |
ECCT/15/12/01 | A Randomized Controlled Trial of ASPIRIN in Nulliparous Pregnant Women(ASPIRIN STUDY) Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN): A Prospective randomized, placebo-controlled, double-blinded clinical trial in western Kenya. |
Principal Investigator(s) 1. Prof Fabian Esamai Omoding Esamai Site(s) in Kenya 1. Amukura, Lukolis,Nasewa,Matayos,Khunyangu, Bumala B (Busia county) 2. Sirisia, Chwele, Bokoli (Bung\'oma county) 3. Makunga, Mumias (Kakamega county) |
16-02-2016 |
View |
473. |
ECCT/15/11/05 | FALCI Study A Randomized, Double-blind, Phase IIb Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine (FQ) with Artefenomel (OZ439) in Adults and Children with Uncomplicated Plasmodium falciparum Malaria. |
Principal Investigator(s) 1. Grace Kiringa Kaguthi Site(s) in Kenya 1. KEMRI Center for Respiratory Diseases Research (Siaya county) 2. KEMRI Walter Reed Kombewa (Kisumu county) 3. KEMRI Kisumu (Kisumu county) |
01-02-2016 |
View |
474. |
ECCT/15/11/04 | VAC040 A Phase 1/2, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety, Tolerability, and Immunogenicity of Stretococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide (PATH-wSP) in Healthy Kenya Young Adults (18 - 40years) and Toddlers (12 - 19months) |
Principal Investigator(s) 1. John Anthony Gerard Scott Site(s) in Kenya KEMRI-Wellcome Trust Research Program |
09-02-2016 |
View |
475. |
ECCT/15/11/02 | EFFECT OF LARYNGEAL MASK AIRWAY MANOMETRY ON POST OPERATIVE SORE THROAT IN SPONTANEOUSLY BREATHING ADULT PATIENTS PRESENTING FOR SURGERY AT AGA KHAN UNIVERSITY HOSPITAL, NAIROBI. |
Principal Investigator(s) 1. Prof Vitalis Mungayi 2. Dr Edna Kemunto Gisore 3. Dr David Njoroge Waruingi Site(s) in Kenya Aga Khan University Hospital Nairobi |
02-12-2015 |
View |
476. |
ECCT/15/11/01 | A5264 A Randomized Evaluation of Antiretroviral Therapy Alone or with Delayed Chemotherapy versus Antiretroviral Therapy with Immediate Adjunctive Chemotherapy for Treatment of Limited Stage AIDS-KS in Resource-Limited Settings (REACT-KS) |
Principal Investigator(s) 1. Dr. Victor Otieno Mudhune Site(s) in Kenya 1. KEMRI CDC (Kisumu county) |
05-05-2016 |
View |
477. |
ECCT/15/10/04 | AZM Azithromycin (AZM) to prevent post-discharge morbidity and mortality in Kenyan children |
Principal Investigator(s) 1. Judd Walson Walson Site(s) in Kenya 1. Homa Bay County referral Hospital (Homa Bay county) 2. Kisii Teaching and referral Hospital (Kisii county) |
09-02-2016 |
View |
478. |
ECCT/15/10/03 | Safer Conception Intervention for Partners (SCIP) Pilot of an mHealth-enhanced, safer conception intervention to reduce HIV-1 risk among Kenyan HIV-1 serodiscordant couples Safer Conception Intervention for Partners (SCIP) |
Principal Investigator(s) 1. Nelly Rwamba Mugo Site(s) in Kenya Thika Partners Study Clinic (Partners in Health Research and Development) affiliated to the University of Washington International Clinical Research Center (ICRC), and KEMRI |
11-01-2016 |
View |
479. |
ECCT/15/10/02 | A non-randomized, open label, single dose, pharmacokinetics, safety and tolerability study of Captopril 50mgs in healthy Kenyan Adults. |
Principal Investigator(s) 1. Bernhards Ragama Ogutu Site(s) in Kenya KEMRI centre for clinical Research |
02-12-2015 |
View |
480. |
ECCT/15/10/01 | VRC01 Monoclonal HIV Antibodies Study Safety and Virologic Effect Of A Human Monoclonal Antibody, VRC-HIVmAb060-00-Ab (VRCOl), With Broad HIV-1 Neutralizing Activity, Administered Intravenously to Adults During Early Acute HIV Infection. |
Principal Investigator(s) 1. Josphat K Kosgei Site(s) in Kenya KEMRI Walter Reed Project Kericho |
20-03-2016 |
View |